Insulin Aspart Injection, Solution
Product Images NDC 70518-3865

Product Visual Gallery

This gallery contains 45 technical images submitted to the FDA as part of the official labeling for Insulin Aspart (NDC 70518-3865). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Insulin Aspart FlexPen prefilled syringe label showing 100 Units/mL (U-100) strength. The label specifies quantity as 5 x 3mL prefilled syringes and indicates it is for single patient use with compatible needles. The labeler is RemedyRepack Inc., and the source manufacturer is Novo Nordisk Inc., Princeton, NJ. The label includes storage instructions and warnings about freezing and light exposure.*

FDA Label Image

Molecular Formula (Image 01)

Diagram showing the amino acid sequence and disulfide bonds of insulin aspart, detailing its A-chain and B-chain arrangements with specific residues labeled and linked by disulfide bridges.*

FDA Label Image

Figure 1 (Image 02)

A line graph showing serum glucose levels (mg/dL) over time (hours). The chart has two plotted lines, one solid and one dashed, depicting changes in glucose concentration from 0 to 6 hours.*

FDA Label Image

Figure 3 (Image 03)

A line graph depicting mean blood glucose levels (mg/dL) over time in minutes. The x-axis represents time ranging from before to after a reference point (R), with intervals labeled R-60 to R+60, including a break in the time axis. The y-axis shows mean blood glucose values from 0 to 180 mg/dL. Two lines with error bars track blood glucose changes over time, showing a decrease before R and an increase after R.*

FDA Label Image

Figure 4 (Image 04)

A line graph depicting free serum insulin levels (mU/L) over time (hours). It shows two trends: one curve rises sharply to a peak under 1 hour, then gradually declines over 6 hours; the other curve maintains a more steady and lower level throughout the same period.*

FDA Label Image

Overview (FlexPen)

An illustrated exploded view of an Insulin Aspart FlexPen injection device, showing its components including the pen cap, rubber stopper, cartridge, cartridge scale, pointer, dose selector, and push-button end. The diagram visually breaks down the FlexPen for assembly or identification.*

FDA Label Image

Novifine And Novofine Plus (Overview)

Illustrations comparing the components of NovoFine and NovoFine Plus needles, showing a big outer needle cap, inner needle cap, needle, and protective tab for each type.*

FDA Label Image

Vial Figure (Image 07)

Illustration showing a vial of Insulin Aspart injection solution with a tamper-resistant cap and rubber stopper under the cap. The vial is depicted in a simple line drawing style, highlighting key components of the vial closure system.*

FDA Label Image

Hand And Vial Figure (Image 08)

A black and white line drawing showing a hand holding a small vial between the thumb and forefinger, likely illustrating the proper way to hold the vial for injection or preparation.*

FDA Label Image

Figure A And Figure B (Image 09)

An instructional diagram showing a two-step process for opening a vial. Figure A illustrates grasping the vial cap, and Figure B shows lifting the cap off, demonstrating how to remove the vial top before use.*

FDA Label Image

Figure C (Image 10)

An instructional illustration labeled "Figure C" showing hands preparing an injection with a syringe and vial. The main image depicts a hand drawing solution from a vial into a syringe, with an inset showing a close-up of the syringe barrel with volume markings. The illustration indicates a downward arrow emphasizing the drawing action.*

FDA Label Image

Figure D (Image 11)

Illustration showing hands preparing an injection by drawing liquid from a vial into a syringe. This instructional diagram is related to the administration of insulin aspart injection, solution for intravenous or subcutaneous use.*

FDA Label Image

Figure E (Image 12)

An instructional illustration showing hands preparing an injection by drawing solution from a vial into a syringe, with an arrow indicating the direction of drawing the solution. The image likely demonstrates proper technique for insulin aspart injection preparation.*

FDA Label Image

Figure F (Image 13)

Illustration depicting a hand holding a vial and syringe vertically, with an arrow pointing downward indicating the action of drawing medication into the syringe from the vial. The illustration is labeled as Figure F, showing a step in medication preparation for injection.*

FDA Label Image

Figure G (Image 14)

Instructional illustration labeled Figure G showing a hand drawing liquid from a vial using a syringe, demonstrating preparation for injection. The image emphasizes proper technique for withdrawing medication.*

FDA Label Image

Figure H (Image 15)

An instructional illustration showing the preparation of an injection with a vial and a syringe. The image depicts a hand holding a vial upside down while drawing solution into a syringe. An inset highlights the syringe filled with the solution. This figure is part of usage instructions for Insulin Aspart injection solution by REMEDYREPACK INC.*

FDA Label Image

Figure I (Image 16)

An instructional illustration depicting a hand pulling a syringe plunger and holding a vial, likely demonstrating the step to draw insulin aspart injection solution from the vial into the syringe prior to administration.*

FDA Label Image

Fig. J (Image 17)

An illustration showing front and back views of a human torso and legs with shaded areas highlighting recommended injection sites for insulin aspart, including the abdomen, upper thighs, and buttocks.*

FDA Label Image

Figure K (Image 18)

An instructional illustration labeled Figure K showing a person using both hands to prepare an injection syringe. One hand is holding the syringe while the other hand is manipulating the plunger, possibly removing air or drawing medication. The image is related to the administration or preparation of Insulin Aspart injection solution.*

FDA Label Image

Figure L (Image 19)

An instructional illustration labeled Figure L showing a person administering an injection subcutaneously. It depicts a hand holding a syringe inserted into the skin of the forearm with an arrow indicating the syringe is being pulled out.*

FDA Label Image

Novotwist Needle (Image 20)

An instructional diagram titled 'NovoTwist' showing components labeled as Big outer needle cap, Inner needle cap, Needle, and Protective tab. Each part is illustrated separately to identify syringe needle safety features.*

FDA Label Image

Pull Off The Pen Cap (Image 21)

An instructional illustration showing a close-up of a hand holding a syringe with a cap being removed by pulling it upward. This image demonstrates the initial step of preparing an insulin aspart injection, solution for administration.*

FDA Label Image

Turn The Dose Selector To Select 2 Units. (Image 22)

An instructional illustration showing a close-up of a user adjusting the dose on an insulin pen injector. The pen is dark-colored and held by two fingers, with an arrow indicating the twisting motion to select the dose. A dose window inset highlights "2 units selected" on the dosage scale.*

FDA Label Image

Tap The Cartridge Gently (Image 23)

An instructional illustration showing a hand pressing the top of an insulin injection pen or syringe with a visible dosage window. The diagram suggests an injection action, likely demonstrating how to administer the insulin aspart injection dose using the device.*

FDA Label Image

Keep The Needle Pointing Upwards (Image 24)

An instructional illustration showing how to activate or prepare an insulin injection pen. It depicts a hand holding the pen with the thumb pushing up on the top, and a small inset image of the pen needle at the base. This image is likely part of dosage preparation instructions for Insulin Aspart injection, solution by RemedyRepack Inc.*

FDA Label Image

Turn The Dose Selector To The Number Of Units You Need To Inject (Image 25)

An instructional illustration depicting the process of selecting dosage units on a pen-like injector device for insulin aspart 100 IU/mL injection solution by RemedyRepack Inc. It shows a hand adjusting a dosage dial with an arrow indicating selection and displays example dosages of 5 units and 24 units on the device's dial window.*

FDA Label Image

Giving The Injection (Image 26)

Illustration showing a hand holding and pressing down on the top of a vial or pen-style injection device, indicating how to operate or activate the dosage mechanism. The image highlights manipulation of the device cap or button for Insulin Aspart injection.*

FDA Label Image

Making Sure That The Full Dose Has Been Given (Image 27)

An instructional illustration showing a syringe needle being inserted into the skin at a shallow angle, likely demonstrating subcutaneous injection technique for insulin aspart injection, solution.*

FDA Label Image

Put The Pen Cap On (Image 28)

An illustration showing a hand holding an insulin pen with an arrow indicating the direction to remove the protective cap from the needle area. This instructional image is associated with the administration of Insulin Aspart injection solution by REMEDYREPACK INC.*

FDA Label Image

Figure A Penfill Cartridge And Needle Components. (Image 41)

Instructional diagram showing components of various pen needles (NovoFine, NovoFine Plus, NovoTwist) including outer needle cap, inner needle cap, needle, and paper tab. It also illustrates parts of a PenFill cartridge compatible insulin delivery device, such as pen cap, cartridge holder, dose pointer, dose counter, dose selector/button, and a 3 mL PenFill cartridge with threaded end for needle attachment, colored band, and rubber plunger.*

FDA Label Image

Diagram B: Attaching The Needle. (Image 43)

Illustration diagram demonstrating use of NovoFine and NovoFine Plus needles along with NovoTwist device. The left panel shows attaching or twisting motion of the needle to the syringe or pen, indicated by a curved arrow. The right panel shows the cap removal from the needle prior to injection, indicated by a downward arrow.*

FDA Label Image

Diagram C: Pull Off The Outer Needle Cap. (Image 44)

An instructional illustration showing how to attach a NovoFine or NovoFine Plus needle and a NovoTwist needle to an insulin pen. The left panel demonstrates twisting the needle onto the pen; the right panel shows the final attachment step with arrows indicating the motion.*

FDA Label Image

Diagram D: Pull Off Inner Needle Cap. (Image 45)

Instructional illustration showing how to connect or use the NovoFine and NovoTwist needles or pen needles for insulin injection. The image includes hand positioning and directional arrows to guide the attachment or use process.*

FDA Label Image

Figure B: Check The Penfill Cartridge. (Image 53)

An instructional illustration showing a hand holding a cylindrical injection pen with a labeled 'Threaded end' at the tip, likely demonstrating part of the insulin aspart injection device.*

FDA Label Image

Figure C: Insert The Cartridge. (Image 58)

An instructional illustration showing hands preparing an insulin pen for injection by attaching or removing a needle. The image includes a downward arrow indicating the direction of needle attachment or removal.*

FDA Label Image

Figure D: Pust The Needle Straight On. (Image 59)

Illustration showing how to use NovoFine, NovoFine Plus, and NovoTwist needles for injection. The diagrams depict proper attachment and positioning of the needle on a syringe or pen device.*

FDA Label Image

Figure E: Pull Off The Outer Needle Cap. (Image 60)

An instructional illustration comparing two types of insulin pen needles: NovoFine NovoFine Plus and NovoTwist. The image shows a hand attaching each needle to an insulin pen, with arrows indicating the direction of attachment.*

FDA Label Image

Figure F: Pull Off The Inner Needle Cap. (Image 61)

An instructional diagram showing two types of insulin pen devices labeled 'NovoFine NovoFine Plus' and 'NovoTwist.' Each side depicts a hand holding an insulin pen with an arrow pointing right, illustrating how to attach or prepare the pen needle for use.*

FDA Label Image

Figure I: Injection Sites (Image 62)

An anatomical illustration showing recommended injection sites for insulin aspart injection solution. The labeled injection areas include the upper arms, abdomen, upper thighs, and buttocks, indicating common places to administer subcutaneous injections.*

FDA Label Image

Figure J: Count Slowly. (Image 63)

An instructional illustration showing a hand holding an insulin injection pen against an arm. A speech bubble instructs to count slowly from 1 to 6 while injecting. The image demonstrates part of the injection process for insulin aspart.*

FDA Label Image

Figure K: Lead The Needle Tip Into The Outer Cap. (Image 65)

An instructional illustration depicting a syringe and needle assembly process. It shows the needle tip aligning with the syringe tip, with directional arrows indicating the needle should be attached to the syringe for use.*

FDA Label Image

Figure L: Unscrew The Needle. (Image 66)

Illustration showing hands holding an insulin cartridge holder with an arrow indicating the removal or attachment of the cartridge cap. Labeled "Cartridge holder," the image demonstrates a step in handling or preparing the injection cartridge for use.*

FDA Label Image

Figure M: Put The Cap On The Device. (Image 67)

An instructional diagram showing a hand holding a pen-type injection device with a blue label. An arrow indicates the injection device is being placed or used on the upper thigh area of a leg.*

FDA Label Image

Figure G: Insulin Squirts. (Image 68)

Insulin Aspart 100 IU/mL injection solution in a vial with an attached needle, labeled by RemedyRepack Inc. The image shows the vial with a needle cap, indicating it is prepared for intravenous or subcutaneous administration.*

FDA Label Image

Figure H: Select Your Dose. (Image 69)

An instructional diagram showing hands adjusting a dose selector on an insulin injection pen. It highlights the dose pointer aligned with a dose counter, with an example of 12 units selected, demonstrating how to set the correct insulin aspart dose before injection.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.